Redmile Group, LLC Annexon, Inc. Transaction History
Redmile Group, LLC
- $952 Million
- Q1 2025
A detailed history of Redmile Group, LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Redmile Group, LLC holds 6,300,644 shares of ANNX stock, worth $15.6 Million. This represents 1.28% of its overall portfolio holdings.
Number of Shares
6,300,644
Previous 6,300,644
-0.0%
Holding current value
$15.6 Million
Previous $32.3 Million
62.38%
% of portfolio
1.28%
Previous 2.53%
Shares
11 transactions
Others Institutions Holding ANNX
# of Institutions
154Shares Held
97MCall Options Held
36.9KPut Options Held
83K-
Satter Management Co., L.P.7.41MShares$18.3 Million71.99% of portfolio
-
Bvf Inc San Francisco, CA7MShares$17.3 Million0.59% of portfolio
-
Black Rock Inc. New York, NY6.59MShares$16.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.38MShares$13.3 Million0.0% of portfolio
-
Bain Capital Life Sciences Investors, LLC Boston, MA5.25MShares$13 Million3.4% of portfolio
About Annexon, Inc.
- Ticker ANNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,617,700
- Market Cap $118M
- Description
- Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...